Literature DB >> 20683605

Predictive value of fluorodeoxyglucose uptake in head and neck cancer: importance of standardization: editorial on EAORL-D-10-00277.

Remco de Bree, Otto S Hoekstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20683605     DOI： 10.1007/s00405-010-1350-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  17 in total

1.  Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.

Authors:  Mitchell Machtay; Mona Natwa; Jocelyn Andrel; Terry Hyslop; P Rani Anne; Jororsali Lavarino; Charles M Intenzo; William Keane
Journal:  Head Neck       Date:  2009-02       Impact factor: 3.147

Review 2.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

3.  Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.

Authors:  Haruo Inokuchi; Takeshi Kodaira; Hiroyuki Tachibana; Tatsuya Nakamura; Natsuo Tomita; Rie Nakahara; Akinori Takada; Nobutaka Mizoguchi; Tsuneo Tamaki; Nobukazu Fuwa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-29       Impact factor: 7.038

4.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

5.  Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

Authors:  H Minn; M Lapela; P J Klemi; R Grénman; S Leskinen; P Lindholm; J Bergman; E Eronen; M Haaparanta; H Joensuu
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

6.  Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.

Authors:  Abdelkarim S Allal; Pavel Dulguerov; Mohamed Allaoua; Charles-André Haenggeli; El Abbes El-Ghazi; Willy Lehmann; Daniel O Slosman
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma.

Authors:  Eva Brun; Elisabeth Kjellén; Jan Tennvall; Tomas Ohlsson; Anders Sandell; Roland Perfekt; Roland Perfekt; Johan Wennerberg; Sven Erik Strand
Journal:  Head Neck       Date:  2002-02       Impact factor: 3.147

8.  Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.

Authors:  Sang Yoon Kim; Jong-Lyel Roh; Mi Ra Kim; Jae Seung Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang-wook Lee; Sung-Bae Kim
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

Review 9.  Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group.

Authors:  P Price; T Jones
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640
View more
  1 in total

1.  Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Authors:  Peter Zbären; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.